Ergoteles’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Ergoteles’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,580	Closed	-$137K	–	1998
2022 Q4	$137K	Hold	13,580	–	–	0.01%	1166
2022 Q3	$134K	Hold	13,580	–	–	﹤0.01%	1304
2022 Q2	$133K	Hold	13,580	–	–	﹤0.01%	1447
2022 Q1	$133K	Hold	13,580	–	–	0.01%	1075
2021 Q4	$132K	Hold	13,580	–	–	0.01%	1115
2021 Q3	$132K	Hold	13,580	–	–	﹤0.01%	1069
2021 Q2	$131K	Buy	+13,580	New	+$133K	﹤0.01%	1362

Ergoteles's MSAC Position: Q1 2023 in Review

Ergoteles sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 13,580 shares — an estimated $137K sold.

Ergoteles first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $137K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Ergoteles reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 13,580 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $137K.
Ergoteles first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Ergoteles's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $137K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.